Nicotinic acetylcholine receptor alpha4 beta2 and alpha3 beta4 subtype (nAChR α4β2/α3β4)

The nicotinic acetylcholine receptor α4β2 and α3β4 subtypes are pentameric ligand-gated ion channels found predominantly in the nervous system. The α4β2 subtype is the most abundant in the human brain and is heavily implicated in nicotine addiction, cognitive function, and epilepsy. It assembles in two stoichiometries (2α:3β and 3α:2β), each with distinct pharmacological and ion permeability profiles. The α3β4 subtype is mainly expressed in autonomic ganglia and select brain regions, contributing to peripheral signal transmission and reward pathways, thus representing a target for both cardiovascular and addiction therapies. Drugs targeting these receptors act primarily through agonism, partial agonism, or antagonism, directly modulating neuronal excitability and synaptic transmission[1][2][3][4][6].

Other names

α4β2 nicotinic acetylcholine receptoralpha4beta2 nAChRα3β4 nicotinic acetylcholine receptoralpha3beta4 nAChRneuronal nicotinic receptor (context-dependent)

Agonists: Activation of channel, increased Na^+ and K^+ permeability, depolarization Partial agonists (e.g., varenicline): Provide submaximal activation, dampen nicotine effects Antagonists: Block acetylcholine/nicotine binding, inhibit channel opening, reduce neurotransmission Desensitization: Prolonged activation leads to non-conducting state Modulation of channel stoichiometry alters ion permeability